Acellular-Convalescent Plasma (A-CP) and New Technologies Introduced by Regen Lab®

LAUSANNE, Switzerland, Sept. 16, 2020 /PRNewswire/ — Convalescent Plasma (CP), also called Passive Antibody Therapy, for the treatment of COVID-19 infected patients was approved by the US-FDA two weeks ago. This great news was based on a nationwide evaluation in 14 U.S. medical institutions, and a report on 20,000 patients shows the safety and benefit of … Read more